Respiri Ltd
RSH
Company Profile
Business description
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.
Contact
432 St Kilda Road
Level 9
MelbourneVIC3004
AUST: +61 411717073
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
2
Stocks News & Analysis
stocks
Australia has the highest dividend yields in the world, so why the endless chase for even higher yields?
Ashley Owen explores why investors' insatiable thirst for higher yields leads to unnecessarily complicating their portfolio.
stocks
These 2 ASX stocks look materially overvalued after earnings
Both of these moated companies annouced solid enough results, but our analysts continue to think the shares are too expensive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,804.20 | 4.60 | 0.05% |
| CAC 40 | 8,164.11 | 121.92 | 1.52% |
| DAX 40 | 22,612.02 | 463.99 | 2.09% |
| Dow JONES (US) | 44,726.64 | 358.08 | 0.81% |
| FTSE 100 | 8,764.72 | 42.72 | -0.49% |
| HKSE | 21,814.37 | 43.55 | -0.20% |
| NASDAQ | 19,907.92 | 257.97 | 1.31% |
| Nikkei 225 | 39,461.47 | 497.77 | 1.28% |
| NZX 50 Index | 12,905.98 | 7.97 | -0.06% |
| S&P 500 | 6,109.13 | 57.16 | 0.94% |
| S&P/ASX 200 | 8,540.00 | 4.70 | 0.06% |
| SSE Composite Index | 3,332.48 | 13.90 | -0.42% |